Vetrichelvan Muthalagu

10PUBLICATIONS
31CO-AUTHORS
Molecular targetsFunctional materialsBiologically active moleculesF-block chemistryGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 20, 2026
Discovery of BMS-159, an Orally Active Imidazotriazine Pan-CK2 Inhibitor for the Treatment of Cancer.

|Mar 30, 2026
From Flat to 3D: Replacing Phenyl Rings with Saturated Bridged Bicyclic Mimetics to Mitigate Bioactivation and Optimize ADME Properties and Oral Bioavailability in Reverse Amide Orientation.

Murugaiah A M Subbaiah, Shruti Surendran, Gaurav Saini

|Oct 01, 2025
Beyond Bioisosteres: Impact of Replacing a Benzene Ring with sp3-Rich Three-Dimensional Saturated Bridged Bicyclic Match Pairs on Biotransformation, Metabolic Stability, and Other ADME Profiles.

Shruti Surendran, Sivashankaran Raju, Naveen Kalyani

|Feb 21, 2025
Shapeshifting Gabriel Amine Synthesis with Iodo-BCPs.

Manivel Pitchai, Nanjundaswamy K C, Sankar Ulaganathan

|Aug 15, 2022
Identification of Monosaccharide Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Human and Mouse Galectin-3.

Chunjian Liu, Prasada Rao Jalagam, Jianxin Feng

|Jun 22, 2022
Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4.

E Scott Priestley, Jacques Banville, Daniel Deon

Pageof 2

Frequent Collaborators

8 joint publications

Anuradha Gupta

3 joint publications

Murugaiah A M Subbaiah

2 joint publications

T G Murali Dhar

2 joint publications

Antonio Ramirez